Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Needle gauge and length effects on human stem cell viability during injection: a comprehensive review

Habiba UE., Shamim S., Greene DL.

Narrative Review, published in Front Cell Dev Biol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Cell Dev Biol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42311508
PMCID
PMC13269218
DOI
10.3389/fcell.2026.1845972

Abstract (original English)

The therapeutic efficacy of stem cell-based treatments depends critically on maintaining high cell viability through the injection process. Mechanical stress induced on cells during passage through injection needles represents a significant source of cell damage that can compromise therapeutic outcomes. This review examines the current understanding of how needle gauge (diameter) and length affect human stem cell viability, exploring the mechanical forces involved, empirical evidence across different stem cell types, and practical implications for clinical protocols. We analyze the competing demands of minimizing tissue trauma through smaller needles while preserving cell viability and provide evidence-based recommendations for optimizing injection parameters across various clinical applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.